GRCL - Gracell Biotechnologies Inc. (GRCL) CEO Dr. William Cao on Q4 2020 Results - Earnings Call Transcript
Gracell Biotechnologies, Inc. (GRCL) Q4 2020 Earnings Conference Call March 10, 2021 08:00 AM ET Company Participants Kevin Xie - Chief Financial Officer Dr. William Cao - Founder and Chief Executive Officer Dr. Martina Sersch - Chief Medical Officer Conference Call Participants Mohit Bansal - Citigroup Kelly Shi - Jefferies Tyler Van Buren - Piper Sandler Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Gracell Biotechnologies Fourth Quarter and Full Year 2020 Conference Call. [Operator Instructions] I would now like to turn the conference over to Kevin Xie, CFO. Please go ahead. Kevin Xie Good morning, and welcome to Gracell's Fourth Quarter Earnings Conference Call and Webcast. This is our first earnings call as a public traded company. Yesterday, we issued a press release announcing unaudited financial results for the 3 months ended December 31, 2020. We encourage everyone to read this press release as
For further details see:
Gracell Biotechnologies, Inc. (GRCL) CEO Dr. William Cao on Q4 2020 Results - Earnings Call Transcript